Patent Application
Provisional
App. No. 63/421,516
· Confirmation No. 7798
EGFR INHIBITORS FOR TREATMENT OF CANCER
Applicant:
Blueprint Medicines Corporation
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2022-11-09 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-11-01 | TR.PROV |
Provisional Cover Sheet (SB16) | 3 | View | |
| 2022-11-01 | ADS |
Application Data Sheet | 8 | View | |
| 2022-11-01 | SPEC |
Specification | 47 | View | |
| 2022-11-01 | DRW |
Drawings-only black and white line drawings | 7 | View | |
| 2022-11-01 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-11-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-11-01 | SPEC |
Specification | 46 | View | |
| 2022-11-01 | ABST |
Abstract | 1 | View |
Inventors
Chiara Conti
Cambridge, MA
Alena Zalutskaya
Cambridge, MA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 86738
- Docket No.
- 134108-83703
- Confirmation No.
- 7798
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/421,516
- Filed
- 2022-11-01
External Links